Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page
- Check5 days agoChange DetectedThe study history now shows recruitment has ended, and a new revision label v3.6.0 was added while the previous revision v3.5.5 was removed.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page history shows a new revision tag (v3.5.5) indicating that the study record was updated since the previous version.SummaryDifference0.1%

- Check19 days agoChange DetectedA new version entry (54, dated 2026-05-21) was added to the record history, introducing new sections for Study Status and Study Identification; the entry dated 2025-09-17 was removed.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing v3.5.3. This indicates an updated version of the study record history interface.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s footer/site revision has been updated from v3.5.2 to v3.5.3, indicating a ClinicalTrials.gov interface/platform version update rather than a change to the study record itself.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision history shows Revision: v3.5.2 added and Revision: v3.5.0 removed.SummaryDifference0.1%

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.